SupplySide West 20-Year Update: The Demise of EphedraSupplySide West 20-Year Update: The Demise of Ephedra
The history of ephedra shows the only time FDA used regulation to ban an ingredient due to its unreasonable risk of illness or injury.
April 5, 2016
From overtly enticing product marketing to highly publicized deaths allegedly linked to excess dietary supplement intake, ephedra caused a maelstrom that could have permanently crippled the industry. In retrospect, many marketers and product developers took note and raised the bar, helping mature the industry to what it is today.
About the Author(s)
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023